ReP USP - Resultado da busca

Artigo de periodico
Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production (2023)
Córneo, Emily S.; Veras, Flávio Protásio ; Gomes, Giovanni F.; Schneider, Ayda Henriques ; Silva, Bruna Manuella Souza; Almeida, Cícero José Luíz dos Ramos; Silva, Camila M.; Martins, Ronaldo B.; Batah, Sabrina Setembre ; Simon, Carla S.; Prestes, Gabriele da S.; Alves Filho, José Carlos Farias ; Arruda, Eurico ; Louzada Júnior, Paulo ; Oliveira, Renê Donizeti Ribeiro de; Fabro, Alexandre Todorovic ; Cunha, Thiago Mattar ; Cunha, Fernando de Queiroz ; Dal-Pizzol, Felipe
Source: Clinical Immunology. Unidades: FMRP, ESALQ
Subjects: COVID-19, NEUTRÓFILOS, CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÓRNEO, Emily S. et al. Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production. Clinical Immunology, v. 257, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2023.109836. Acesso em: 14 nov. 2024.
APA
Córneo, E. S., Veras, F. P., Gomes, G. F., Schneider, A. H., Silva, B. M. S., Almeida, C. J. L. dos R., et al. (2023). Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production. Clinical Immunology, 257, 1-12. doi:10.1016/j.clim.2023.109836
NLM
Córneo ES, Veras FP, Gomes GF, Schneider AH, Silva BMS, Almeida CJL dos R, Silva CM, Martins RB, Batah SS, Simon CS, Prestes G da S, Alves Filho JCF, Arruda E, Louzada Júnior P, Oliveira RDR de, Fabro AT, Cunha TM, Cunha F de Q, Dal-Pizzol F. Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production [Internet]. Clinical Immunology. 2023 ; 257 1-12.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.clim.2023.109836
Vancouver
Córneo ES, Veras FP, Gomes GF, Schneider AH, Silva BMS, Almeida CJL dos R, Silva CM, Martins RB, Batah SS, Simon CS, Prestes G da S, Alves Filho JCF, Arruda E, Louzada Júnior P, Oliveira RDR de, Fabro AT, Cunha TM, Cunha F de Q, Dal-Pizzol F. Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production [Internet]. Clinical Immunology. 2023 ; 257 1-12.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.clim.2023.109836
Artigo de periodico
Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress (2022)
Silva-Neto, Pedro V. da; Valle, Valéria Beatriz do; Fuzo, Carlos Alessandro; Fernandes, Talita Morais; Toro, Diana Mota; Silva, Thais Fernanda de Campos Fraga da; Basile, Patrícia Adriana; Carvalho, Jonatan Constança Silva de; Pimentel, Vinícius Eduardo; Pérez, Malena Martínez; Oliveira, Camilla Narjara Simão; Rodrigues, Lilian Cataldi ; Bastos, Victor Alexandre Félix; Tella, Sandra de Oliveira Conde; Martins, Ronaldo Bragança; Degiovani, Augusto Marcussi; Ostini, Fátima M.; Feitosa, Marley Ribeiro; Parra, Rogério Serafim; Vilar, Fernando Crivelenti; Gaspar, Gilberto Gambero; Rocha, José Joaquim Ribeiro da ; Féres, Omar; Arruda, Eurico; Maruyama, Sandra R.; Russo, Elisa Maria de Sousa ; Viana, Angelina Lettiere ; Santos, Isabel Kinney Ferreira de Miranda; Bonato, Vânia Luiza Deperon; Cardoso, Cristina Ribeiro de Barros; Tanus-Santos, José Eduardo ; Donadi, Eduardo Antônio; Faccioli, Lucia Helena ; Dias-Baruffi, Marcelo; Fernandes, Ana Paula Morais ; Gerlach, Raquel Fernanda; Sorgi, Carlos Arterio
Source: Biomolecules. Unidades: FORP, FCFRP, FMRP, EERP, FFCLRP
Subjects: METALOPROTEINASES, PEROXIDASE, LIPÍDEOS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA-NETO, Pedro V. da et al. Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress. Biomolecules, v. 12, n. 5, p. 1-20, 2022Tradução . . Disponível em: https://doi.org/10.3390/biom12050604. Acesso em: 14 nov. 2024.
APA
Silva-Neto, P. V. da, Valle, V. B. do, Fuzo, C. A., Fernandes, T. M., Toro, D. M., Silva, T. F. de C. F. da, et al. (2022). Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress. Biomolecules, 12( 5), 1-20. doi:10.3390/biom12050604
NLM
Silva-Neto PV da, Valle VB do, Fuzo CA, Fernandes TM, Toro DM, Silva TF de CF da, Basile PA, Carvalho JCS de, Pimentel VE, Pérez MM, Oliveira CNS, Rodrigues LC, Bastos VAF, Tella S de OC, Martins RB, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJR da, Féres O, Arruda E, Maruyama SR, Russo EM de S, Viana AL, Santos IKF de M, Bonato VLD, Cardoso CR de B, Tanus-Santos JE, Donadi EA, Faccioli LH, Dias-Baruffi M, Fernandes APM, Gerlach RF, Sorgi CA. Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress [Internet]. Biomolecules. 2022 ; 12( 5): 1-20.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/biom12050604
Vancouver
Silva-Neto PV da, Valle VB do, Fuzo CA, Fernandes TM, Toro DM, Silva TF de CF da, Basile PA, Carvalho JCS de, Pimentel VE, Pérez MM, Oliveira CNS, Rodrigues LC, Bastos VAF, Tella S de OC, Martins RB, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJR da, Féres O, Arruda E, Maruyama SR, Russo EM de S, Viana AL, Santos IKF de M, Bonato VLD, Cardoso CR de B, Tanus-Santos JE, Donadi EA, Faccioli LH, Dias-Baruffi M, Fernandes APM, Gerlach RF, Sorgi CA. Matrix metalloproteinases on severe COVID-19 lung disease pathogenesis: cooperative actions of MMP-8/MMP-2 axis on immune response through HLA-G shedding and oxidative stress [Internet]. Biomolecules. 2022 ; 12( 5): 1-20.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/biom12050604
Artigo de periodico
Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial (2022)
Crippa, José Alexandre de Souza ; Pacheco, Júlia Cozar; Zuardi, Antônio Waldo ; Guimarães, Francisco Silveira ; Campos, Alline Cristina de ; Osório, Flávia de Lima ; Loureiro, Sonia Regina ; Santos, Rafael Guimarães dos ; souza, José Diogo dos Santos; Ushirohira, Juliana Mayumi; Ferreira, Rafael Rinaldi; Costa, Karla Cristinne Mancini ; Scomparin, Davi Silveira; Scarante, Franciele Franco ; Santos, Isabela Pires dos; Mechoulam, Raphael; Kapczinski, Flávio; Fonseca, Benedito Antonio Lopes da ; Esposito, Danillo Lucas Alves ; Passos, Afonso Dinis Costa ; Dal-Fabbro, Amaury Lelis ; Bellissimo-Rodrigues, Fernando ; Arruda, Eurico ; Scarpelini, Sandro ; Andraus, Maristela Haddad; Nather Junior, Júlio Cesar; Wada, Danilo Tadao; Santos, Marcel Koenigkam ; Santos, Antonio Carlos dos ; Busatto Filho, Geraldo ; Hallak, Jaime Eduardo Cecilio
Source: Cannabis And Cannabinoid Research. Unidades: FMRP, FM
Subjects: COVID-19, CANABINOIDES, ENSAIO CLÍNICO, DOENÇAS INFECCIOSAS, MEDICINA INTERNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial. Cannabis And Cannabinoid Research, v. 7, n. 5, p. 658-669, 2022Tradução . . Disponível em: https://doi.org/10.1089/can.2021.0093. Acesso em: 14 nov. 2024.
APA
Crippa, J. A. de S., Pacheco, J. C., Zuardi, A. W., Guimarães, F. S., Campos, A. C. de, Osório, F. de L., et al. (2022). Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial. Cannabis And Cannabinoid Research, 7( 5), 658-669. doi:10.1089/can.2021.0093
NLM
Crippa JA de S, Pacheco JC, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Loureiro SR, Santos RG dos, souza JD dos S, Ushirohira JM, Ferreira RR, Costa KCM, Scomparin DS, Scarante FF, Santos IP dos, Mechoulam R, Kapczinski F, Fonseca BAL da, Esposito DLA, Passos ADC, Dal-Fabbro AL, Bellissimo-Rodrigues F, Arruda E, Scarpelini S, Andraus MH, Nather Junior JC, Wada DT, Santos MK, Santos AC dos, Busatto Filho G, Hallak JEC. Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial [Internet]. Cannabis And Cannabinoid Research. 2022 ; 7( 5): 658-669.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1089/can.2021.0093
Vancouver
Crippa JA de S, Pacheco JC, Zuardi AW, Guimarães FS, Campos AC de, Osório F de L, Loureiro SR, Santos RG dos, souza JD dos S, Ushirohira JM, Ferreira RR, Costa KCM, Scomparin DS, Scarante FF, Santos IP dos, Mechoulam R, Kapczinski F, Fonseca BAL da, Esposito DLA, Passos ADC, Dal-Fabbro AL, Bellissimo-Rodrigues F, Arruda E, Scarpelini S, Andraus MH, Nather Junior JC, Wada DT, Santos MK, Santos AC dos, Busatto Filho G, Hallak JEC. Cannabidiol for COVID-19 patients with mild to moderate symptoms (CANDIDATE study): a randomized, double-blind, placebo-controlled clinical trial [Internet]. Cannabis And Cannabinoid Research. 2022 ; 7( 5): 658-669.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1089/can.2021.0093
Artigo de periodico
Kallikrein 5 inhibition by the Lympho-epithelial Kazal-type related inhibitor hinders matriptase-dependent carcinogenesis (2021)
Silva, Elaine Zayas Marcelino da ; Fraga-Silva, Thais Fernanda de Campos ; Yuan, Yao; Alves, Márcia Gaião; Públio, Gabriel Azevedo ; Fonseca, Carol Kobori da; Kodama, Márcio Hideki; Vieira, Gabriel Viliod ; Candido, Marina Ferreira; Innocentini, Lara Maria Alencar Ramos ; Miranda, Mateus Gonçalves; Silva, Alfredo Ribeiro da ; Alves Filho, José Carlos Farias ; Bonato, Vânia Luiza Deperon ; Iglesias-Bartolome, Ramiro; Sales, Katiuchia Uzzun
Source: Cancers. Unidade: FMRP
Subjects: CALICREINA, CARCINOGÊNESE, CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS DE CABEÇA E PESCOÇO, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Elaine Zayas Marcelino da et al. Kallikrein 5 inhibition by the Lympho-epithelial Kazal-type related inhibitor hinders matriptase-dependent carcinogenesis. Cancers, v. 13, n. 17, p. 1-18, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13174395. Acesso em: 14 nov. 2024.
APA
Silva, E. Z. M. da, Fraga-Silva, T. F. de C., Yuan, Y., Alves, M. G., Públio, G. A., Fonseca, C. K. da, et al. (2021). Kallikrein 5 inhibition by the Lympho-epithelial Kazal-type related inhibitor hinders matriptase-dependent carcinogenesis. Cancers, 13( 17), 1-18. doi:10.3390/cancers13174395
NLM
Silva EZM da, Fraga-Silva TF de C, Yuan Y, Alves MG, Públio GA, Fonseca CK da, Kodama MH, Vieira GV, Candido MF, Innocentini LMAR, Miranda MG, Silva AR da, Alves Filho JCF, Bonato VLD, Iglesias-Bartolome R, Sales KU. Kallikrein 5 inhibition by the Lympho-epithelial Kazal-type related inhibitor hinders matriptase-dependent carcinogenesis [Internet]. Cancers. 2021 ; 13( 17): 1-18.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/cancers13174395
Vancouver
Silva EZM da, Fraga-Silva TF de C, Yuan Y, Alves MG, Públio GA, Fonseca CK da, Kodama MH, Vieira GV, Candido MF, Innocentini LMAR, Miranda MG, Silva AR da, Alves Filho JCF, Bonato VLD, Iglesias-Bartolome R, Sales KU. Kallikrein 5 inhibition by the Lympho-epithelial Kazal-type related inhibitor hinders matriptase-dependent carcinogenesis [Internet]. Cancers. 2021 ; 13( 17): 1-18.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3390/cancers13174395

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation